Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Abbott Laboratories (ABT) – Abbott Laboratories Price Today

24H
1W
1M
3M
YTD
1Y
5Y

DBV Technologies plans BLA submission for VIASKIN® Peanut patch in kids 4-7 after FDA collaboration.

DBV Technologies is preparing to submit a Biologics License Application (BLA) for its VIASKIN® Peanut patch aimed at children aged 4 to 7 years. The company has engaged in detailed discussions with the FDA to ensure a thorough and efficient review pr...

Market News
30 minutes ago
Dbv Technologies
Bullish
news icon
pluang ai news

Fidelity Advisor Series VIII increases voting rights in Renk Group AG to 3.23%.

Fidelity Advisor Series VIII, based in Boston, has raised its voting rights stake in Renk Group AG to 3.23% as of June 24, 2026. This includes 3.04% direct voting rights and 0.19% through stock loan instruments. The total voting rights are based on 1...

Market News
3 hours ago
Na
Neutral
pluang ai news

Fidelity Advisor Series VIII increases stake in Renk Group AG to 3.23%

Fidelity Advisor Series VIII has increased its voting rights in Renk Group AG to 3.23% as of June 24, 2026. This includes 3.04% voting rights attached to shares and 0.19% through stock loan instruments. The total voting rights represent a significant...

Market News
3 hours ago
Na
Neutral
pluang ai news

No buybacks of cooperative investment certificates reported by CRCAM Toulouse for week of June 22-26, 2026

CRCAM Toulouse announced that no repurchases of its cooperative investment certificates (CCI) were made during the week of June 22 to June 26, 2026. This update is part of their regular weekly disclosure on CCI transactions, reflecting no activity in...

Market News
3 hours ago
Na
Neutral
pluang ai news

Hyperliquid Strategies stock joins Russell 3000, Russell 2000, and S&P Global BMI indexes.

Hyperliquid Strategies Inc (HSI) announced that its common stock has been added to the Russell 3000 and Russell 2000 indexes as of June 29, 2026, and to the S&P Global Broad Market Index since June 22, 2026. These inclusions reflect the company's gro...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
pluang ai news

UMH Properties added to Russell 2000 Value-Defensive Index for stability and quality recognition

UMH Properties, a REIT specializing in manufactured home communities, was added to the Russell 2000 Value-Defensive Index after the June 26, 2026 market close. This index highlights smaller-cap stocks with high quality and low volatility, reflecting ...

Market News
4 hours ago
GlobeNewsWire
Bullish
news icon
pluang ai news

Silo Pharma advances PTSD treatment with nasal spray device study ahead of FDA meeting

Silo Pharma is conducting a robustness study on its microchip-based nasal spray delivery system for SPC-15, a PTSD treatment, to evaluate device performance and formulation stability. This study supports their plan to request a Type C meeting with th...

Market News
4 hours ago
GlobeNewsWire
Bullish
news icon
pluang ai news

SpaceX shares rebound with bullish options bets amid mobile carrier buyout rumors

SpaceX shares have recovered after a 35% drop from their post-IPO peak, driven by strong bullish activity in options trading. Traders are buying significantly more call options than puts, signaling confidence in the stock's upside. The rally follows ...

Market News
4 hours ago
CNBC
Bullish
news icon
pluang ai news

Digital Realty announces $2.35B secondary stock offering by Blackstone after data center acquisition closes.

Digital Realty Trust announced a $2.35 billion underwritten public offering of common stock by Blackstone affiliates, contingent on the closing of Digital Realty's acquisition of Blackstone's interests in two joint ventures. The shares offered are no...

Company Fundamentals
4 hours ago
GlobeNewsWire
Neutral
pluang ai news

FDA clears Gain Therapeutics' IND for GT-02287, advancing Parkinson's drug to Phase 2 trials in 3Q26

Gain Therapeutics received FDA clearance for its Investigational New Drug (IND) application for GT-02287, enabling the start of Phase 2 clinical trials for Parkinson’s disease in the U.S. during the third quarter of 2026. GT-02287 showed promising Ph...

Market News
4 hours ago
GlobeNewsWire
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $163.94B
  • Sector
    Health
  • 3M Drawdown
    -20.31%
  • Enterprise Value
    $190.69B
  • Dividend Yield
    2.68%
  • Trading Activity
    41% Buy | 59% Sell
  • Typical Hold Time
    93 days
$92.8
52W Low: $82.57
11 May 2026
52W High: $136.62
22 Sep 2025

Abbott Laboratories (ABT) is currently valued at a market capitalization of $163.94B, with an enterprise value of $190.69B. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $136.62, highlighting its annual price range. Over the past three months, Abbott Laboratories has recorded a drawdown of -20.31%, reflecting recent price volatility. Abbott Laboratories offers a dividend yield of 2.68%, with the most recent dividend of $0.63 paid on 15 Apr 26. On average, investors hold Abbott Laboratories for approximately 93 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!